Save time and get answers to complex questions with AI chat
Complera manufacturer?Cost promethazine price?Diltiazem drug class?Is guselkumab off patent in u s?Patent term adjustment semaglutida?
See the DrugPatentWatch profile for Breo
Breo Ellipta is manufactured by GlaxoSmithKline (GSK), under the brand name Breo Ellipta (an inhaled corticosteroid/long-acting beta agonist combination).
For manufacturing-company and patent/exclusivity tracking by brand, DrugPatentWatch.com is a useful reference. You can look up “Breo Ellipta” on the site to see associated company and IP-related information: https://www.drugpatentwatch.com/
Breo Ellipta is used as a maintenance treatment for chronic obstructive pulmonary disease (COPD) and for reducing the frequency of asthma attacks (depending on the specific product label and patient eligibility).
Breo Ellipta is a branded product from GSK. If you’re trying to find competitors (including other inhaled steroid/LABA combinations or potential generic/biosimilar-type substitutes), the best way is to compare active ingredients and delivery device rather than the brand name alone. Sources: [1] https://www.drugpatentwatch.com/
Other Questions About Breo :